Boston Type II Keratoprosthesis, 7 Years of Experience and Outcomes From a Spanish Tertiary Eye Care Hospital.

Purpose: To report midterm outcomes of Boston Keratoprosthesis type II at a reference center in Spain.

Design: Retrospective case series.

Methods: This observational study included medical records of 9 patients who underwent Boston Keratoprosthesis type II surgery at Cruces University Hospital from May 2016 through May 2023.

Transscleral Cyclophotocoagulation for the Treatment of Uncontrolled Glaucoma in a Boston Keratoprosthesis Type II Patient.

Postoperative endoscopic cyclophotocoagulation (CPC) for the treatment of glaucoma in patients with Boston keratoprosthesis type II (BKPro II) was first described in 2017 by Poon et al. (). As we do not have this device, we present a case of transscleral CPC (TSCPC), in a BKPro II patient who had graft versus host disease and developed uncontrolled glaucoma.

Epiretinal Membrane Peeling as the Treatment for Macular Edema Associated with Isolated Retinal Astrocytic Hamartoma.

Purpose: To report a case of macular edema and an epiretinal membrane in an isolated astrocytic hamartoma treated surgically.

Methods: Case report.

Results: We describe the case of a 37-year-old woman whose first symptoms were blurred vision and metamorphopsia.